• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit/AskCarlat AI
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Authors » Noah Capurso, MD, MHS
Noah Capurso, MD, MHS

Noah Capurso, MD, MHS

Dr. Capurso is the Assistant Director of Addiction Services at Connecticut Valley Hospital and an associate clinical professor of psychiatry at the Yale University School of Medicine. Prior to joining Connecticut Valley Hospital, he was the medical director of the Detoxification & Addiction Stabilization Service and the Psychosocial Residential Rehabilitation Program at the West Haven Veterans Administration Hospital. He completed medical school, psychiatry residency, and addiction psychiatry fellowship at Yale.

Articles
Products

ARTICLES

Clinical Guidance

Perioperative Management of Patients on Medications for Opioid Use Disorder

January 1, 2025
Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

  • Medications for opioid use disorder (MOUD) can complicate pain control during and after surgery. 



  • Read More
    Clinical Guidance

    Example of a Modified Finnegan Neonatal Abstinence Score

    January 1, 2025
    Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

    Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

  • Example of a Modified Finnegan Neonatal Abstinence Score



  • Read More
    Clinical Guidance

    How to Manage and Taper Buprenorphine

    January 1, 2025
    Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

    Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    After you have initiated buprenorphine, see patients weekly at first to make sure the dose is right.




    Read More
    Clinical Guidance

    How to Discuss and Initiate Extended-Release Naltrexone (Vivitrol)

    January 1, 2025
    Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

    Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Extended-release naltrexone injection (XR-NTX) is an effective medication for some patients with opioid use disorder (OUD).




    Read More
    Clinical Guidance

    How to Discuss and Initiate Buprenorphine

    January 1, 2025
    Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

    Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Induction refers to the process of starting a patient on buprenorphine (with or without naloxone; the combination product is most often preferred).




    Read More
    Clinical Guidance

    How to Choose the Right Medications for Opioid Use Disorder

    January 1, 2025
    Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

    Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    The purpose of this fact sheet is not to provide details on pharmacology or the use of these medications, but rather to help you decide which might be best for a given patient.




    Read More
    Clinical Guidance

    Clinical Opiate Withdrawal Scale

    January 1, 2025
    Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

    Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    The Clinical Opiate Withdrawal Scale (COWS) is an 11-item scale designed to be administered by a clinician.




    Read More
    Clinical Guidance

    Practical Tips for Using the Clinical Opiate Withdrawal Scale (COWS)

    January 1, 2025
    Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

    Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    The Clinical Opiate Withdrawal Scale (COWS) is an 11-item scale used for rating the degree of opioid withdrawal.




    Read More
    Clinical Guidance

    Opioid Withdrawal: Time Course and Symptoms

    January 1, 2025
    Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

    Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    It’s hard to predict whether a particular person will experience withdrawal or how severe their symptoms will be. 




    Read More
    Clinical Guidance

    Opioid Withdrawal Management

    January 1, 2025
    Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

    Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Getting patients with opioid use disorder (OUD) completely off opioids, so-called “detox,” is generally not advisable.




    Read More
    View All Articles by Noah Capurso, MD, MHS
    Try The New AskCarlat AI

    Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

    Available In The Carlat Toolkit
    Free Psychiatry Updates
    The latest unbiased psychiatric information sent to your inbox.
    Specify Your Interests
    Featured Book
    • PB5e_3DCover.png

      Psychiatry Practice Boosters, Fifth Edition (2026)

      This fifth edition teaches you the key points of 66 of the most clinically relevant studies in...
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2839304851.jpg
      Addiction Treatment

      Medication or Therapy? A Clinical Framework for Substance Use Disorders

      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.